NYSE - Nasdaq Real Time Price USD

Doximity, Inc. (DOCS)

Compare
41.69 +0.32 (+0.77%)
As of 2:31 PM EDT. Market Open.
Loading Chart for DOCS
DELL
  • Previous Close 41.37
  • Open 41.60
  • Bid 41.61 x 1000
  • Ask 41.63 x 1100
  • Day's Range 41.41 - 41.99
  • 52 Week Range 19.89 - 41.99
  • Volume 655,363
  • Avg. Volume 1,709,638
  • Market Cap (intraday) 7.74B
  • Beta (5Y Monthly) 1.27
  • PE Ratio (TTM) 52.11
  • EPS (TTM) 0.80
  • Earnings Date Nov 7, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 34.29

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

www.doximity.com

827

Full Time Employees

March 31

Fiscal Year Ends

Recent News: DOCS

View More

Performance Overview: DOCS

Trailing total returns as of 9/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

DOCS
48.68%
S&P 500
19.98%

1-Year Return

DOCS
109.60%
S&P 500
32.47%

3-Year Return

DOCS
51.57%
S&P 500
28.44%

5-Year Return

DOCS
1.26%
S&P 500
34.13%

Compare To: DOCS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DOCS

View More

Valuation Measures

Annual
As of 9/24/2024
  • Market Cap

    7.68B

  • Enterprise Value

    6.94B

  • Trailing P/E

    51.71

  • Forward P/E

    39.84

  • PEG Ratio (5yr expected)

    2.42

  • Price/Sales (ttm)

    16.97

  • Price/Book (mrq)

    8.41

  • Enterprise Value/Revenue

    14.07

  • Enterprise Value/EBITDA

    35.00

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    32.53%

  • Return on Assets (ttm)

    10.61%

  • Return on Equity (ttm)

    16.86%

  • Revenue (ttm)

    493.63M

  • Net Income Avi to Common (ttm)

    160.55M

  • Diluted EPS (ttm)

    0.80

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    750.49M

  • Total Debt/Equity (mrq)

    1.54%

  • Levered Free Cash Flow (ttm)

    142.84M

Research Analysis: DOCS

View More

Company Insights: DOCS

Research Reports: DOCS

View More

People Also Watch